Funding to support commercialization of ExoView™ system BOSTON–NanoView Biosciences, an emerging leader in the field of exosome detection and characterization, today announced the closing of a $10 million Series B financing led by Northpond Ventures. Existing investors, including Sands Capital Ventures and PBM Capital Group, participated in the financing round. Proceeds will be used to […]
£1.25 million already secured based on pre-money valuation of £18.2 million Additional funding will be used to further accelerate product development and company growth Daresbury, UK: Arcis Biotechnology (“Arcis”), the nucleic acid sample preparation solution provider, today announced the closing of a £1.25 million investment round and a decision to overfund by an additional £0.5 million, […]
WILSONVILLE, Ore.– FLIR Systems, Inc. (NASDAQ: FLIR) announced today it has received an award from the United States Department of Defense (DOD) Joint Program Executive Office for Chemical Biological Radiological and Nuclear Defense (JPEO-CBRND) in support of the Multi-Phase Chemical Agent Detector (MPCAD) program. The Other Transaction Authority Agreement (OTA) is valued at $28.7 million, with execution extending […]
Phase II grant to support development of innovative exosome characterization platform BOSTON — NanoView Biosciences, an emerging leader in the field of exosome characterization, has been awarded a National Science Foundation Small Business Innovation Research Phase II grant in the amount of $750,000. The program will focus on completing development of the ExoView™ system, the company’s innovative instrument and […]
Worldwide Success of Company’s Aurora Flow Cytometry Systems Accelerates Momentum The Cytek Aurora delivers on Cytek’s promise to make high-quality flow cytometry accessible to a larger number of researchers and clinicians. The Series C funding round will facilitate the expansion of Cytek’s footprint around the world. FREMONT, Calif. — Cytek Biosciences Inc., the preeminent provider of […]
OptibriumTM, Intellegens and Medicines Discovery Catapult awarded funding to apply machine learning in drug discovery Cambridge–Funding to support Artificial Intelligence (AI) in drug discovery takes a significant step forward today as Optibrium, Intellegens, and Medicines Discovery Catapult secure a grant from Innovate UK to fund a £1 million project. The program will see Optibrium, which creates software to […]
Optibrium, Intellegens and Medicines Discovery Catapult awarded funding to apply machine learning in drug discovery Funding to support Artificial Intelligence (AI) in drug discovery takes a significant step forward today as Optibrium™, Intellegens, and Medicines Discovery Catapult secure a grant from Innovate UK to fund a £1 million project. The program will see Optibrium, which […]
Integrating CNV analysis into a NextGen sequencing clinical analytics platform Bozeman, MT — Golden Helix, Inc., an industry-leading genomic analytics company that specializes in clinical Next-Gen Sequencing analysis software, has announced today that the National Institutes of Health awarded them a Phase 2 SBIR Grant 2R44 GM125432-02 “Integrating CNV analysis into a NextGen sequencing clinical analytics […]
Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that it has received notice from the U.S. Food and Drug Administration (FDA) that it has been awarded a new funded cooperative agreement, for $250,000 per year for up to two […]
System integrates phenotypic and genomic information at massive scale to define heterogeneity in cell populations, accelerate research, drug discovery and drug development DURHAM, N.C.–Celldom, Inc. today announced that it has been awarded a $1.5 million Phase II Small Business Innovation Research (SBIR) grant by the National Institutes of Health’s National Institute of General Medical Sciences […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
